HIF1A and myocardial infarction: The administration of HIF-1α/VP16 had a similar therapeutic effect as VEGF in a rat MI model [120], and the overexpression of HIF-1α resulted in reduced infarct size, upregulation of VEGF and nitric oxide synthase expression, and improved capillary density in a mouse MI model [121].